Breaking News, Promotions & Moves

Akari Therapeutics Appoints Abizer Gaslightwala President and CEO

Gaslightwala is a former SVP for US Oncology at Jazz and held several leadership roles at Amgen, Pfizer, and Johnson & Johnson.

By: Rachel Klemovitch

Assistant Editor

Akari Therapeutics, a biotechnology company developing bi-functional antibody-drug conjugates (ADCs) to treat cancer, announced the appointment of Abizer Gaslightwala as President and Chief Executive Officer (CEO), effective April 21, 2025. As previously announced, Gaslightwala was appointed to Akari’s Board of Directors in December 2024. Current President and CEO Samir R. Patel, M.D., will remain a member of the company’s Board of Directors. Patel commented, “During my tenure, I am proud ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters